CMPI News

The IPO market is expected to remain active in the week ahead with nine IPOs scheduled to raise $2.7 billion.  Canadian digital service provider TELUS International (TIXT) plans to raise $800 million at a $6.4 billion market cap. The company provides customer service outsourcing and end-to-end customer experience and digital technology solutions and...read more

Eight IPOs and nine SPACs entered the public markets this past week led by BigCommerce (BIGC), which soared 201% in the best first-day pop for an IPO over $100 million in 15 years. E-commerce platform BigCommerce (BIGC) priced above the upwardly revised range to raise $216 million at a $1.8 billion market cap. With accelerating growth and...read more

Checkmate Pharmaceuticals, a clinical stage immuno-oncology biotech developing therapies for solid tumors, raised $75 million by offering 5 million shares at $15, within the range of $14 to $16. Checkmate Pharmaceuticals plans to list on the Nasdaq under the symbol CMPI. BofA Securities, Jefferies and BMO Capital Markets acted as lead managers on the deal....read more

Checkmate Pharmaceuticals, a clinical stage immuno-oncology biotech developing therapies for solid tumors, announced terms for its IPO on Monday. The Cambridge, MA-based company plans to raise $75 million by offering 5 million shares at a price range of $14 to $16. At the midpoint of the proposed range, Checkmate Pharmaceuticals would command a fully diluted market value of...read more